- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article (WORD)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (1405)
- Timeline of Article Publication Processes (5)
- Authors Evaluation (3)
- Article Quality Tracking (1)
- Reference Citation Analysis (System.Threading.Tasks.Task`1[System.Int32])
-
Full Article (HTML) (127) -
Full Article (PDF) (40) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4794)
All Articles published online
|
Publishing Process of This Article
|
Jul 21, 2019 (publication date) through May 20, 2022
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cao J, Kong FH, Liu X, Wang XB. Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2019; 25(27): 3649-3663 [PMID: 31367163 DOI: 10.3748/wjg.v25.i27.3649] |
|---|---|
| URL: | https://www.wjgnet.com/2218-6190/full/v25/i27/3649.htm |
| Number | Citing Articles |
| 1 |
Danijel Galun, Dragana Mijac, Aleksandar Filipovic, Aleksandar Bogdanovic, Marko Zivanovic, Dragan Masulovic. Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective. Journal of Personalized Medicine 2022; 12(2): 149 doi: 10.3390/jpm12020149
|
| 2 |
Rachel M. Golonka, Matam Vijay-Kumar. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 171 doi: 10.1016/bs.acr.2020.10.004
|
| 3 |
Gbemisola Lawal, Yao Xiao, Amir A. Rahnemai-Azar, Diamantis I. Tsilimigras, Ming Kuang, Anargyros Bakopoulos, Timothy M. Pawlik. The Immunology of Hepatocellular Carcinoma. Vaccines 2021; 9(10): 1184 doi: 10.3390/vaccines9101184
|
| 4 |
Linh Pham, Konstantina Kyritsi, Tianhao Zhou, Ludovica Ceci, Leonardo Baiocchi, Lindsey Kennedy, Sanjukta Chakraborty, Shannon Glaser, Heather Francis, Gianfranco Alpini, Keisaku Sato. The Functional Roles of Immune Cells in Primary Liver Cancer. The American Journal of Pathology 2022; doi: 10.1016/j.ajpath.2022.02.004
|
| 5 |
Uasim Harkus, Miriam Wankell, Pranavan Palamuthusingam, Craig McFarlane, Lionel Hebbard. Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data. Seminars in Cancer Biology 2022; doi: 10.1016/j.semcancer.2022.01.005
|
| 6 |
Yuting Qiu, Haobo Li, Jiaheng Xie, Xinwei Qiao, Jing Wu. Identification of ABCC5 Among ATP-Binding Cassette Transporter Family as a New Biomarker for Hepatocellular Carcinoma Based on Bioinformatics Analysis. International Journal of General Medicine 2021; : 7235 doi: 10.2147/IJGM.S333904
|
| 7 |
Xiao-Wan Bo, Li-Ping Sun, Song-Yuan Yu, Hui-Xiong Xu. Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions. World Journal of Gastrointestinal Oncology 2021; 13(10): 1397-1411 doi: 10.4251/wjgo.v13.i10.1397
|
| 8 |
Justin K. H. Liu, Andrew F. Irvine, Rebecca L. Jones, Adel Samson. Immunotherapies for hepatocellular carcinoma. Cancer Medicine 2022; 11(3): 571 doi: 10.1002/cam4.4468
|
| 9 |
Zuzanna Sas, Ewa Cendrowicz, Isabel Weinhäuser, Tomasz P. Rygiel. Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options. International Journal of Molecular Sciences 2022; 23(7): 3778 doi: 10.3390/ijms23073778
|
| 10 |
Xiongpei Huang, Zecheng Qiu, Liusheng Li, Bin Chen, Peiyuan Huang. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma. Aging 2021; 13(16): 20698 doi: 10.18632/aging.203456
|
| 11 |
Shuo Wang, Xiaoli Wang, Xinna Zhou, Herbert Kim Lyerly, Michael A. Morse, Jun Ren. DC-CIK as a widely applicable cancer immunotherapy. Expert Opinion on Biological Therapy 2020; 20(6): 601 doi: 10.1080/14712598.2020.1728250
|
| 12 |
Marcelo M. Rodríguez, Agostina Onorato, María José Cantero, Luciana Domínguez, Juan Bayo, Esteban Fiore, Mariana García, Catalina Atorrasagasti, Ali Canbay, Mariana Malvicini, Guillermo D. Mazzolini. 4-methylumbelliferone-mediated polarization of M1 macrophages correlate with decreased hepatocellular carcinoma aggressiveness in mice. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85491-0
|
| 13 |
Harriet Roddy, Tim Meyer, Claire Roddie. Novel Cellular Therapies for Hepatocellular Carcinoma. Cancers 2022; 14(3): 504 doi: 10.3390/cancers14030504
|
| 14 |
Qiu-Zhong Pan, Qing Liu, Yu-Qing Zhou, Jing-Jing Zhao, Qi-Jing Wang, Yong-Qiang Li, Yan Tang, Jia-Mei Gu, Jia He, Shi-Ping Chen, De-Sheng Weng, Jian-Chuan Xia. CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma. Cancer Immunology, Immunotherapy 2020; 69(5): 825 doi: 10.1007/s00262-020-02486-y
|
| 15 |
Guodai Hong, Silun Xie, Zikuan Guo, Diping Zhang, Sihai Ge, Suqin Zhang, Wenbin Gao. Progression-Free Survival of a Patient with Advanced Hepatocellular Carcinoma Treated with Adoptive Cell Therapy Using Natural Killer Cells: A Case Report. OncoTargets and Therapy 2022; : 255 doi: 10.2147/OTT.S344707
|
| 16 |
Harry Cheuk Hay Lau, Joseph Jao-Yiu Sung, Jun Yu. Gut microbiota: impacts on gastrointestinal cancer immunotherapy. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2020.1869504
|
| 17 |
Haipeng Zhu, Xiaojun Liu. Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal Malignancies. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.666340
|
| 18 |
Tong Wu, Linzhi Zhang, Zhen Zeng, Tao Yan, Jiamin Cheng, Xiaojie Miao, Yinying Lu. Complete Response to PD-1 Inhibitor in Primary Hepatocellular Carcinoma Patients Post-Progression on Bi-Specific Antibody Conjugated CIK Cell Treatment: A Report of Two Cases. OncoTargets and Therapy 2021; : 5447 doi: 10.2147/OTT.S333604
|
| 19 |
Eleni-Myrto Trifylli, Evangelos Koustas, Nikolaos Papadopoulos, Panagiotis Sarantis, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Michalis V. Karamouzis. An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma. Life 2022; 12(5): 665 doi: 10.3390/life12050665
|
| 20 |
He Huang, Shilei Xu, Aidong Chen, Fen Li, Jiezhong Wu, Xusheng Tu, Kunpeng Hu, Makoto Endo. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients. Analytical Cellular Pathology 2021; 2021: 1 doi: 10.1155/2021/6697407
|
| 21 |
Konstantinos Damiris, Hamza Abbad, Nikolaos Pyrsopoulos. Cellular based treatment modalities for unresectable hepatocellular carcinoma. World Journal of Clinical Oncology 2021; 12(5): 290-308 doi: 10.5306/wjco.v12.i5.290
Abstract(201) |
Core Tip(210) |
Full Article(HTML)(1667)
|
Full Article (PDF)-4716K(245)
|
Full Article (Word)-268K(51)
|
Audio-246K(4)
|
Peer-Review Report-221K(62)
|
Answering Reviewers-109K(46)
|
Times Cited (0)
|
Total Visits (3951)
|
Open
|
| 22 |
Li Zhang, Jia Ding, Hui-Yan Li, Zhong-Hua Wang, Jian Wu. Immunotherapy for advanced hepatocellular carcinoma, where are we?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188441 doi: 10.1016/j.bbcan.2020.188441
|